Latent vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare AI automating prior authorization documentation by reviewing patient records; $13.1M from General Catalyst and YC achieving $2.4M revenue competing with Cohere Health for pharmacy workflow automation.
About
Latent is a San Francisco-based healthcare AI company automating clinical operations for pharmacy and medication access workflows — using AI to review patient medical records, generate evidence-based prior authorization documentation, and streamline the clinical justification process that currently requires pharmacists and clinical staff to spend significant time on administrative documentation that delays patients' access to medications. Founded in 2022 and a Y Combinator W23 graduate, Latent raised $13.1 million from General Catalyst and Y Combinator, achieving $2.4 million in revenue in 2024.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.